Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
50
HQY Quote, Financials, Valuation and Earnings
Last price:
$92.44
Seasonality move
:
8.41%
Day range:
$92.17 - $93.50
52-week range:
$74.07 - $116.65
Dividend yield:
0%
P/E ratio:
42.37x
P/S ratio:
6.31x
P/B ratio:
3.70x
Volume:
456.3K
Avg. volume:
905.7K
1-year change:
-3.38%
Market cap:
$7.9B
Revenue:
$1.2B
EPS (TTM):
$2.18
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
HQY
HealthEquity, Inc.
|
$321M | $0.91 | 6.6% | 204.96% | $121.36 |
|
HSTM
HealthStream, Inc.
|
$75.5M | $0.18 | 2.66% | 9.65% | $34.00 |
|
SCNX
Scienture Holdings, Inc.
|
-- | -- | -- | -- | -- |
|
SDGR
Schrödinger, Inc.
|
$49.6M | -$0.74 | -5.78% | -69.19% | $27.22 |
|
SLP
Simulations Plus, Inc.
|
$18.1M | $0.20 | -3.59% | 90.19% | $22.33 |
|
VEEV
Veeva Systems, Inc.
|
$792.6M | $1.95 | 12.44% | 63.59% | $312.18 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
HQY
HealthEquity, Inc.
|
$92.45 | $121.36 | $7.9B | 42.37x | $0.00 | 0% | 6.31x |
|
HSTM
HealthStream, Inc.
|
$23.83 | $34.00 | $707M | 34.92x | $0.03 | 0.52% | 2.42x |
|
SCNX
Scienture Holdings, Inc.
|
$0.54 | -- | $21.8M | -- | $1.50 | 0% | 10.51x |
|
SDGR
Schrödinger, Inc.
|
$18.38 | $27.22 | $1.4B | -- | $0.00 | 0% | 5.24x |
|
SLP
Simulations Plus, Inc.
|
$19.18 | $22.33 | $386.4M | 49.91x | $0.06 | 0% | 4.89x |
|
VEEV
Veeva Systems, Inc.
|
$223.15 | $312.18 | $36.7B | 43.36x | $0.00 | 0% | 12.11x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
HQY
HealthEquity, Inc.
|
32.52% | 2.262 | 12.7% | 3.49x |
|
HSTM
HealthStream, Inc.
|
4.2% | -0.579 | 1.83% | 1.12x |
|
SCNX
Scienture Holdings, Inc.
|
3% | 4.395 | 13% | 0.13x |
|
SDGR
Schrödinger, Inc.
|
25.75% | 0.566 | 7.54% | 2.97x |
|
SLP
Simulations Plus, Inc.
|
0.58% | -0.404 | 0.11% | 4.71x |
|
VEEV
Veeva Systems, Inc.
|
1.26% | 1.435 | 0.19% | 7.42x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
HQY
HealthEquity, Inc.
|
$201.1M | $79.9M | 5.97% | 9.01% | 24.79% | $127.2M |
|
HSTM
HealthStream, Inc.
|
$39.1M | $7.6M | 5.55% | 5.82% | 9.9% | $10.5M |
|
SCNX
Scienture Holdings, Inc.
|
$567.7K | -$4.4M | -23.89% | -24.88% | -739.19% | -$3.2M |
|
SDGR
Schrödinger, Inc.
|
$28M | -$45.9M | -35.36% | -46.11% | -84.58% | -$62.4M |
|
SLP
Simulations Plus, Inc.
|
$13M | $3M | -36.48% | -36.69% | 14.71% | $7.1M |
|
VEEV
Veeva Systems, Inc.
|
$609.2M | $240.9M | 13.6% | 13.78% | 29.69% | $182.9M |
HealthEquity, Inc. vs. Competitors
-
Which has Higher Returns HQY or HSTM?
HealthStream, Inc. has a net margin of 16.05% compared to HealthEquity, Inc.'s net margin of 7.96%. HealthEquity, Inc.'s return on equity of 9.01% beat HealthStream, Inc.'s return on equity of 5.82%.
Company Gross Margin Earnings Per Share Invested Capital HQYHealthEquity, Inc.62.41% $0.59 $3.2B HSTMHealthStream, Inc.51.19% $0.20 $364.5M -
What do Analysts Say About HQY or HSTM?
HealthEquity, Inc. has a consensus price target of $121.36, signalling upside risk potential of 31.53%. On the other hand HealthStream, Inc. has an analysts' consensus of $34.00 which suggests that it could grow by 42.68%. Given that HealthStream, Inc. has higher upside potential than HealthEquity, Inc., analysts believe HealthStream, Inc. is more attractive than HealthEquity, Inc..
Company Buy Ratings Hold Ratings Sell Ratings HQYHealthEquity, Inc.8 2 0 HSTMHealthStream, Inc.2 3 0 -
Is HQY or HSTM More Risky?
HealthEquity, Inc. has a beta of 0.176, which suggesting that the stock is 82.354% less volatile than S&P 500. In comparison HealthStream, Inc. has a beta of 0.452, suggesting its less volatile than the S&P 500 by 54.844%.
-
Which is a Better Dividend Stock HQY or HSTM?
HealthEquity, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. HealthStream, Inc. offers a yield of 0.52% to investors and pays a quarterly dividend of $0.03 per share. HealthEquity, Inc. pays -- of its earnings as a dividend. HealthStream, Inc. pays out 17.1% of its earnings as a dividend. HealthStream, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios HQY or HSTM?
HealthEquity, Inc. quarterly revenues are $322.2M, which are larger than HealthStream, Inc. quarterly revenues of $76.5M. HealthEquity, Inc.'s net income of $51.7M is higher than HealthStream, Inc.'s net income of $6.1M. Notably, HealthEquity, Inc.'s price-to-earnings ratio is 42.37x while HealthStream, Inc.'s PE ratio is 34.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthEquity, Inc. is 6.31x versus 2.42x for HealthStream, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HQYHealthEquity, Inc.6.31x 42.37x $322.2M $51.7M HSTMHealthStream, Inc.2.42x 34.92x $76.5M $6.1M
-
Which has Higher Returns HQY or SCNX?
Scienture Holdings, Inc. has a net margin of 16.05% compared to HealthEquity, Inc.'s net margin of -611.42%. HealthEquity, Inc.'s return on equity of 9.01% beat Scienture Holdings, Inc.'s return on equity of -24.88%.
Company Gross Margin Earnings Per Share Invested Capital HQYHealthEquity, Inc.62.41% $0.59 $3.2B SCNXScienture Holdings, Inc.96.22% -$0.19 $85.2M -
What do Analysts Say About HQY or SCNX?
HealthEquity, Inc. has a consensus price target of $121.36, signalling upside risk potential of 31.53%. On the other hand Scienture Holdings, Inc. has an analysts' consensus of -- which suggests that it could grow by 1160.5%. Given that Scienture Holdings, Inc. has higher upside potential than HealthEquity, Inc., analysts believe Scienture Holdings, Inc. is more attractive than HealthEquity, Inc..
Company Buy Ratings Hold Ratings Sell Ratings HQYHealthEquity, Inc.8 2 0 SCNXScienture Holdings, Inc.0 0 0 -
Is HQY or SCNX More Risky?
HealthEquity, Inc. has a beta of 0.176, which suggesting that the stock is 82.354% less volatile than S&P 500. In comparison Scienture Holdings, Inc. has a beta of 2.959, suggesting its more volatile than the S&P 500 by 195.932%.
-
Which is a Better Dividend Stock HQY or SCNX?
HealthEquity, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Scienture Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $1.50 per share. HealthEquity, Inc. pays -- of its earnings as a dividend. Scienture Holdings, Inc. pays out 81.44% of its earnings as a dividend. Scienture Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios HQY or SCNX?
HealthEquity, Inc. quarterly revenues are $322.2M, which are larger than Scienture Holdings, Inc. quarterly revenues of $590K. HealthEquity, Inc.'s net income of $51.7M is higher than Scienture Holdings, Inc.'s net income of -$3.6M. Notably, HealthEquity, Inc.'s price-to-earnings ratio is 42.37x while Scienture Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthEquity, Inc. is 6.31x versus 10.51x for Scienture Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HQYHealthEquity, Inc.6.31x 42.37x $322.2M $51.7M SCNXScienture Holdings, Inc.10.51x -- $590K -$3.6M
-
Which has Higher Returns HQY or SDGR?
Schrödinger, Inc. has a net margin of 16.05% compared to HealthEquity, Inc.'s net margin of -60.37%. HealthEquity, Inc.'s return on equity of 9.01% beat Schrödinger, Inc.'s return on equity of -46.11%.
Company Gross Margin Earnings Per Share Invested Capital HQYHealthEquity, Inc.62.41% $0.59 $3.2B SDGRSchrödinger, Inc.51.61% -$0.45 $432.8M -
What do Analysts Say About HQY or SDGR?
HealthEquity, Inc. has a consensus price target of $121.36, signalling upside risk potential of 31.53%. On the other hand Schrödinger, Inc. has an analysts' consensus of $27.22 which suggests that it could grow by 48.11%. Given that Schrödinger, Inc. has higher upside potential than HealthEquity, Inc., analysts believe Schrödinger, Inc. is more attractive than HealthEquity, Inc..
Company Buy Ratings Hold Ratings Sell Ratings HQYHealthEquity, Inc.8 2 0 SDGRSchrödinger, Inc.7 2 0 -
Is HQY or SDGR More Risky?
HealthEquity, Inc. has a beta of 0.176, which suggesting that the stock is 82.354% less volatile than S&P 500. In comparison Schrödinger, Inc. has a beta of 1.566, suggesting its more volatile than the S&P 500 by 56.591%.
-
Which is a Better Dividend Stock HQY or SDGR?
HealthEquity, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Schrödinger, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealthEquity, Inc. pays -- of its earnings as a dividend. Schrödinger, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HQY or SDGR?
HealthEquity, Inc. quarterly revenues are $322.2M, which are larger than Schrödinger, Inc. quarterly revenues of $54.3M. HealthEquity, Inc.'s net income of $51.7M is higher than Schrödinger, Inc.'s net income of -$32.8M. Notably, HealthEquity, Inc.'s price-to-earnings ratio is 42.37x while Schrödinger, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthEquity, Inc. is 6.31x versus 5.24x for Schrödinger, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HQYHealthEquity, Inc.6.31x 42.37x $322.2M $51.7M SDGRSchrödinger, Inc.5.24x -- $54.3M -$32.8M
-
Which has Higher Returns HQY or SLP?
Simulations Plus, Inc. has a net margin of 16.05% compared to HealthEquity, Inc.'s net margin of -330.59%. HealthEquity, Inc.'s return on equity of 9.01% beat Simulations Plus, Inc.'s return on equity of -36.69%.
Company Gross Margin Earnings Per Share Invested Capital HQYHealthEquity, Inc.62.41% $0.59 $3.2B SLPSimulations Plus, Inc.64% -$3.35 $124.5M -
What do Analysts Say About HQY or SLP?
HealthEquity, Inc. has a consensus price target of $121.36, signalling upside risk potential of 31.53%. On the other hand Simulations Plus, Inc. has an analysts' consensus of $22.33 which suggests that it could grow by 16.44%. Given that HealthEquity, Inc. has higher upside potential than Simulations Plus, Inc., analysts believe HealthEquity, Inc. is more attractive than Simulations Plus, Inc..
Company Buy Ratings Hold Ratings Sell Ratings HQYHealthEquity, Inc.8 2 0 SLPSimulations Plus, Inc.3 4 0 -
Is HQY or SLP More Risky?
HealthEquity, Inc. has a beta of 0.176, which suggesting that the stock is 82.354% less volatile than S&P 500. In comparison Simulations Plus, Inc. has a beta of 1.164, suggesting its more volatile than the S&P 500 by 16.414%.
-
Which is a Better Dividend Stock HQY or SLP?
HealthEquity, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Simulations Plus, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.06 per share. HealthEquity, Inc. pays -- of its earnings as a dividend. Simulations Plus, Inc. pays out -48.18% of its earnings as a dividend.
-
Which has Better Financial Ratios HQY or SLP?
HealthEquity, Inc. quarterly revenues are $322.2M, which are larger than Simulations Plus, Inc. quarterly revenues of $20.4M. HealthEquity, Inc.'s net income of $51.7M is higher than Simulations Plus, Inc.'s net income of -$67.3M. Notably, HealthEquity, Inc.'s price-to-earnings ratio is 42.37x while Simulations Plus, Inc.'s PE ratio is 49.91x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthEquity, Inc. is 6.31x versus 4.89x for Simulations Plus, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HQYHealthEquity, Inc.6.31x 42.37x $322.2M $51.7M SLPSimulations Plus, Inc.4.89x 49.91x $20.4M -$67.3M
-
Which has Higher Returns HQY or VEEV?
Veeva Systems, Inc. has a net margin of 16.05% compared to HealthEquity, Inc.'s net margin of 29.12%. HealthEquity, Inc.'s return on equity of 9.01% beat Veeva Systems, Inc.'s return on equity of 13.78%.
Company Gross Margin Earnings Per Share Invested Capital HQYHealthEquity, Inc.62.41% $0.59 $3.2B VEEVVeeva Systems, Inc.75.09% $1.40 $7.1B -
What do Analysts Say About HQY or VEEV?
HealthEquity, Inc. has a consensus price target of $121.36, signalling upside risk potential of 31.53%. On the other hand Veeva Systems, Inc. has an analysts' consensus of $312.18 which suggests that it could grow by 39.9%. Given that Veeva Systems, Inc. has higher upside potential than HealthEquity, Inc., analysts believe Veeva Systems, Inc. is more attractive than HealthEquity, Inc..
Company Buy Ratings Hold Ratings Sell Ratings HQYHealthEquity, Inc.8 2 0 VEEVVeeva Systems, Inc.13 9 2 -
Is HQY or VEEV More Risky?
HealthEquity, Inc. has a beta of 0.176, which suggesting that the stock is 82.354% less volatile than S&P 500. In comparison Veeva Systems, Inc. has a beta of 1.053, suggesting its more volatile than the S&P 500 by 5.265%.
-
Which is a Better Dividend Stock HQY or VEEV?
HealthEquity, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Veeva Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealthEquity, Inc. pays -- of its earnings as a dividend. Veeva Systems, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HQY or VEEV?
HealthEquity, Inc. quarterly revenues are $322.2M, which are smaller than Veeva Systems, Inc. quarterly revenues of $811.2M. HealthEquity, Inc.'s net income of $51.7M is lower than Veeva Systems, Inc.'s net income of $236.2M. Notably, HealthEquity, Inc.'s price-to-earnings ratio is 42.37x while Veeva Systems, Inc.'s PE ratio is 43.36x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthEquity, Inc. is 6.31x versus 12.11x for Veeva Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HQYHealthEquity, Inc.6.31x 42.37x $322.2M $51.7M VEEVVeeva Systems, Inc.12.11x 43.36x $811.2M $236.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
